Cause of death, by non-communicable diseases, ages 5-14 in Mali
Mali: Cause of death, by non-communicable diseases, ages 5-14 was 22.5% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14 in Mali, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 5-14.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 5-14 in Mali stood at 22.5%.
The figure is down 1.2% on the previous year and up 11.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14 in Mali peaked at 22.8% in 2020 and was at its lowest, 15.8%, in 2000.
Mali ranks 146th of 185 countries on this measure, in the bottom quarter.
Cause of death, by non-communicable diseases, ages 5-14 in Mali, year by year
| Year | % of total deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 15.8% | — |
| 2010 | 20.2% | +27.9% |
| 2015 | 21.3% | +5.6% |
| 2019 | 22.0% | +3.2% |
| 2020 | 22.8% | +3.6% |
| 2021 | 22.5% | -1.2% |
Mali compared with similar countries
- Mali's 22.5% is above the median for low income countries, which is 21.1%, 1.1× the median. (25 countries reporting)
- Mali's 22.5% is above the median for Sub-Saharan Africa, which is 18.1%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 15.8% | 15.8% | 15.8% | 1 |
| 2010s | 21.2% | 20.2% | 22.0% | 3 |
| 2020s | 22.7% | 22.5% | 22.8% | 2 |
Countries ranked near Mali
- 143 Burkina Faso 23.1% compare
- 144 Nigeria 23.0% compare
- 145 Seychelles 22.8% compare
- 147 Solomon Islands 22.3% compare
- 148 Eritrea 22.3% compare
- 149 Rwanda 22.1% compare
More health data for Mali
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.18 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 878 deaths per 1,000 people (2090)
- Number of infants who die before age 1 24,194 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 14 (2025)
- Population ages 00-04, female, annual growth rate 2.27 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0853 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.19 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14 in Mali?
- Cause of death, by non-communicable diseases, ages 5-14 in Mali was 22.5% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14 recorded in Mali?
- The highest recorded value was 22.8% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14 recorded in Mali?
- The lowest recorded value was 15.8% in 2000.
- How does Mali rank for cause of death, by non-communicable diseases, ages 5-14?
- Mali ranks 146th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14 rising or falling in Mali?
- Over the last ten years it is up 11.5%. The long-run trend across the full record is rising.
- Where does this Mali data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.